{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:44:26Z","timestamp":1761237866121,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T00:00:00Z","timestamp":1400198400000},"content-version":"vor","delay-in-days":866,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/s10156-011-0352-9","type":"journal-article","created":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T00:29:31Z","timestamp":1324945771000},"page":"753-755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide"],"prefix":"10.1016","volume":"18","author":[{"given":"Keiichiro","family":"Uemura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoaki","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokumasa","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuro","family":"Tomiyasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-011-0352-9_bib0005","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.juro.2008.05.045","article-title":"Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that has relapsed after initial maximum androgen blockade","volume":"179","author":"Suzuki","year":"2008","journal-title":"J Urol"},{"key":"10.1007\/s10156-011-0352-9_bib0010","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/1097-0142(20001215)89:12<2570::AID-CNCR9>3.0.CO;2-H","article-title":"Low dose of oral dexamethasone for hormone-refractory prostate carcinoma","volume":"89","author":"Nishimura","year":"2000","journal-title":"Cancer"},{"key":"10.1007\/s10156-011-0352-9_bib0015","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1007\/s10156-011-0352-9_bib0020","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa041318","article-title":"Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer","volume":"351","author":"Petrylak","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1007\/s10156-011-0352-9_bib0025","first-page":"155","article-title":"Chemotherapy for endocrine resistant cancer for the prostate","volume":"359","author":"Eisenberger","year":"1990","journal-title":"Prog Clin Biol Res"},{"key":"10.1007\/s10156-011-0352-9_bib0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-5347(17)58751-0","article-title":"The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate","volume":"116","author":"Scott","year":"1976","journal-title":"J Urol"},{"key":"10.1007\/s10156-011-0352-9_bib0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0090-4295(88)90450-5","article-title":"Hormone-refractory metastatic prostate cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide","volume":"32","author":"Murphy","year":"1988","journal-title":"Urology"},{"key":"10.1007\/s10156-011-0352-9_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.2990040102","article-title":"A comparative clinical trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: prognostic factors and response","volume":"4","author":"DeWys","year":"1983","journal-title":"Prostate"},{"key":"10.1007\/s10156-011-0352-9_bib0045","doi-asserted-by":"crossref","first-page":"657","DOI":"10.5980\/jpnjurol1989.89.657","article-title":"Combination chemotherapy with cis-platinum and ifosfamide for hormone unresponsive prostate cancer","volume":"89","author":"Maki","year":"1998","journal-title":"Jpn J Urol"},{"key":"10.1007\/s10156-011-0352-9_bib0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1569-9056(02)00005-2","article-title":"Chemotherapy for the treatment of hormone-refractory prostate cancer","volume":"1","author":"Petrylak","year":"2002","journal-title":"Eur Urol Supply"},{"key":"10.1007\/s10156-011-0352-9_bib0055","first-page":"1783","article-title":"Intra-arterial chemotherapy for relapsed and hormone-resistant prostate cancer using reservoir system","volume":"17","author":"Ueno","year":"1990","journal-title":"Jpn Cancer Chemother"},{"key":"10.1007\/s10156-011-0352-9_bib0060","doi-asserted-by":"crossref","first-page":"682","DOI":"10.5980\/jpnjurol1989.87.682","article-title":"Intermittent intra-arterial chemotherapy for the treatment of patients with bladder cancer or prostate cancer using implantable injection pump","volume":"87","author":"Sumiyoshi","year":"1996","journal-title":"Jpn J Urol"},{"key":"10.1007\/s10156-011-0352-9_bib0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00686915","article-title":"Intra-arterial chemotherapy using a reservoir for endocrine refractory prostate cancer","volume":"35","author":"Kuriyama","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1007\/s10156-011-0352-9_bib0070","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijrobp.2009.02.084","article-title":"Radiotherapy and concomitant intra-arterial docetaxel combined with systemic 5-fluorouracil and cisplatin for oropharyngeal cancer: a preliminary report-improvement of locoregional control of oropharyngeal cancer","volume":"75","author":"Oikawa","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X12702556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X12702556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-011-0352-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:48:50Z","timestamp":1761158930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X12702556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"alternative-id":["S1341321X12702556"],"URL":"https:\/\/doi.org\/10.1007\/s10156-011-0352-9","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-011-0352-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}